Short Interest Ratio: 15.85

9.2

Chattem (CHTT), a maker of over-the-counter toiletries, is in similarly healthy shape, with a long history of rising earnings, good cash flow and a willingness to pay down debt. In this case Berwyn bought a single-B-rated bond, the 7% due March 1, 2014.

Cramer spoke with Zan Guerry, Chairman and CEO of Chattem (CHTT), to discuss the company's outlook after its recent earnings miss.
...
Cramer said if investors feel the recession is here to stay, then Chattem is a good stock to own. But if they feel as he does that things are improving, this might not be the best time to own the stock.("Mad Money Recap," 4-9-09)

Cramer recommended it on his show. I checked in to it. Looked like a solid company.

These are my notes on their last cc..7-10-08 Transcript 5 stars Nymph's Take: So unloved by the street but it is a company that works. CEO Guerry- 7 Analyst We bring you a lot of good news including strong earnings, excellent consumer sales and very strong financial performance..they have purchased over 400,000 shares in recent period...28% increase. Heat Therapy money loser, essentially discontinued, last 4 wks their top six brands up 10% yoy and all brands up 7%. Gold Brand up 21%/63% for lotion in last 4 wks. There was a one time charge for Icey Hott recall. NO RECESSIONARY PRESSURE...petroleum is a significant factor...price increases 5.4%. Looking for accustions. Increased freight costs 30-40% but they are bulk packaging to avoid it. Private Labels not really going after them. Great June. In cc they indicated they did have revenues at 117M level...you exclude Incy Hot Therapy which was recalled and adjust for the addition month of sales from the brands acquired from JNJ...stock was down even with an upgrade.

If the Fed Keeps Cutting, Buy These Stocks
Charles Reinhard, director of portfolio strategy at asset manager Neuberger Berman, says Don't fight the Fed" -- buy Chattem and Johnson & Johnson instead."

Click here to watch the video.

selsun blue &
other common
brands

Just look at their products. They're growing and are very much a best-of-the-best mfr.

25% earnings growth rate for 2008.